Epigenetics alternation in lung fibrosis and lung cancer
Respiratory disease including interstitial lung diseases (ILDs) and lung cancer is a group of devastating diseases that linked with increased morbidity and healthcare burden. However, respiratory diseases cannot be fully explained by the alternation of genetic information. Genetic studies described...
Príomhchruthaitheoirí: | Xueren Li, Chunjing Feng, Shouchun Peng |
---|---|
Formáid: | Alt |
Teanga: | English |
Foilsithe / Cruthaithe: |
Frontiers Media S.A.
2022-11-01
|
Sraith: | Frontiers in Cell and Developmental Biology |
Ábhair: | |
Rochtain ar líne: | https://www.frontiersin.org/articles/10.3389/fcell.2022.1060201/full |
Míreanna comhchosúla
Míreanna comhchosúla
-
Epigenetic Therapy in Lung Cancer
de réir: Stephen V Liu, et al.
Foilsithe / Cruthaithe: (2013-05-01) -
Epigenetics as a versatile regulator of fibrosis
de réir: Yangdan Liu, et al.
Foilsithe / Cruthaithe: (2023-03-01) -
Progress of Epigenetic Methylation in Lung Cancer Research
de réir: Shaowei ZHANG, et al.
Foilsithe / Cruthaithe: (2017-09-01) -
Epigenetic mechanisms and their effects on cancer incidence and treatment: a review study
de réir: Reyhane Hoshyar, et al.
Foilsithe / Cruthaithe: (2015-07-01) -
Epigenetic modification in liver fibrosis: Promising therapeutic direction with significant challenges ahead
de réir: Runping Liu, et al.
Foilsithe / Cruthaithe: (2024-03-01)